IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Millions of Americans live with chronic kidney disease, and healthcare providers rely on venous access devices to reach a patient’s bloodstream for treatments like hydration, nutrition infusion, antibiotics, chemotherapy and dialysis. About 90.0% of hospitalized patients in the United States received vascular access treatment using these devices according to Healthcare Global. An aging population has increased this reliance because more people over 50 require intensive and long-term care, prompting manufacturers to scale production to meet the growing clinical needs. Manufacturers have likewise responded by accelerating innovation in safer device models as reimbursement rules have shifted, reduced payment for hospital-acquired infections that have pushed hospitals toward antimicrobial venous access devices. As a result, revenue is expected to climb at a CAGR of 4.3% through 2025. In 2025 alone, the industry is forecast to increase 2.3% to nearly $7.5 billion.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Venous Access Device Manufacturing industry in the United States includes market sizing, forecasting, data and analysis from 2015-2030. The most recent publication was released November 2025.
The Venous Access Device Manufacturing industry in the United States operates under the NAICS industry code OD4091. Manufactures of venous access devices, such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs), dialysis catheters, implantable ports and catheter securement devices. Medical professionals use these devices to access a patient’s bloodstream through the veins and deliver a variety of treatments including hydration, nutritional infusion, antibiotics, chemotherapy and dialysis. Related terms covered in the Venous Access Device Manufacturing industry in the United States include peripherally inserted central catheter (picc), central venous catheter, dialysis catheter and implantable port.
Products and services covered in Venous Access Device Manufacturing industry in the United States include Peripherally inserted central catheters (PICCs), Central venous catheters (CVCs) and Implantable ports.
Companies covered in the Venous Access Device Manufacturing industry in the United States include Baxter International Inc. and Becton, Dickinson And Company.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Venous Access Device Manufacturing industry in the United States.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
The Products and Markets chapter covers detailed product and service segmentation, analysis of major markets and international trade data for the for the Venous Access Device Manufacturing industry in the United States.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Venous Access Device Manufacturing industry in the United States.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Venous Access Device Manufacturing industry in the United States. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
The Companies chapter covers Key Takeaways, Market Share and Companies in the Venous Access Device Manufacturing industry in the United States. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Venous Access Device Manufacturing industry in the United States. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Venous Access Device Manufacturing industry in the United States. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Venous Access Device Manufacturing industry in the United States.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Venous Access Device Manufacturing industry in the United States is $7.5bn in 2026.
There are 193 businesses in the Venous Access Device Manufacturing industry in the United States, which has grown at a CAGR of 4.0 % between 2020 and 2025.
The Venous Access Device Manufacturing industry in the United States is likely to be impacted by import tariffs with imports accounting for a moderate share of industry revenue.
The Venous Access Device Manufacturing industry in the United States is likely to be significantly impacted by export tariffs with exports accounting for a high share of industry revenue.
The market size of the Venous Access Device Manufacturing industry in the United States has been growing at a CAGR of 4.3 % between 2020 and 2025.
Over the next five years, the Venous Access Device Manufacturing industry in the United States is expected to grow.
The biggest companies operating in the Venous Access Device Manufacturing industry in the United States are Baxter International Inc. and Becton, Dickinson And Company
Manufacturing venous access devices and Manufacturing peripherally inserted central catheters (PICCs) are part of the Venous Access Device Manufacturing industry in the United States.
The company holding the most market share in the Venous Access Device Manufacturing industry in the United States is Baxter International Inc..
The level of competition is moderate and increasing in the Venous Access Device Manufacturing industry in the United States.